HPV genotyping in cervical cancer in Northern Thailand. Adapting the linear array HPV assay for use on paraffin-embedded tissue

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 555-560

  Siriaunkgul, Sumalee ^a   Suwiwat, Supaporn ^b   Settakorn, Jongkolnee ^a   Khunamornpong, Surapan ^a   Tungsinmunkong, Kobkul ^b   Boonthum, Anusorn ^a   Chaisuksunt, Vipavadee ^a   Lekawanvijit, Suree ^a   Srisomboon, Jatupol ^a   Thorner, Paul S ^c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Genotyping; Human papillomavirus (HPV); Linear array; Squamous cell carcinoma; Uterine cervix

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THAILAND; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 39549106687     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.016     Document Type: Article

References (23)

1. National Cancer Institute. Surveillance epidemiology and end-results (1998), Department of Health and Human Service, Washington (DC)
2. Ferlay J., Bray F., Pisani P., and Parkin D. Globocan 2000: cancer incidence, morality, and prevalence worldwide, version 1.0. IARC CancerBase vol. 5 (2001), IARC Press, Lyon
3. Mandelblatt J.S., Lawrence W.F., Gaffikin L., Limpahayom K.K., Lumbiganon P., Warakamin S., et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 94 (2002) 1469-1483
4. Sriplung H., Sontipong S., Martin N., Wiangnon S., Vootiprux V., Cheirsilpa A., et al. Cancer in Thailand vol. III (2003) 49-50
5. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 (2007) 1-24
6. Bosch F.X. The rolling dossier of cervical cancer prevention. HPV today (August 9 2006) 2. http://www.hpvtoday.com http://www.hpvtoday.com
7. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 (2006) 12-17
8. Woo Y.L., Damay I., Stanley M., Crawford R., and Sterling J. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods 142 (2007) 226-230
9. Remmerbach T.W., Brinckmann U.G., Hemprich A., Chekol M., Kuhndel K., and Liebert U.G. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30 (2004) 302-308
10. Schalasta G., Rosenthal T., and Grothe M. Roche AMPLICOR human papilloma virus (HPV) and LINEAR ARRAY HPV tests will profit from automated DNA extraction. Clin Lab 53 (2007) 131-133
11. Stevens M.P., Garland S.M., and Tabrizi S.N. Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods 135 (2006) 124-126
12. Huang L.W., Chao S.L., Chen P.H., and Chou H.P. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol 29 (2004) 271-276
13. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
14. Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J., et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90 (1998) 50-57
15. Mutirangura A., Sriuranpong V., Termrunggraunglert W., Tresukosol D., Lertsaguansinchai P., Voravud N., et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions. Br J Cancer 78 (1998) 933-939
16. Bhattarakosol P., Poonnaniti A., and Niruthisad S. Detection and typing of human papillomavirus in cervical cancer in Thai. J Med Assoc Thai 79 suppl 1 (1996) S56-S64
17. Thomas D.B., Ray R.M., Koetsawang A., Kiviat N., Kuypers J., Qin Q., et al. Human papillomaviruses and cervical cancer in Bangkok: I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 153 (2001) 723-731
18. Settheetham-Ishida W., Kanjanavirojkul N., Kularbkaew C., and Ishida T. Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol 49 (2005) 417-421
19. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
20. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 (2007) 621-632
21. Giuliani L., Coletti A., Syrjanen K., Favalli C., and Ciotti M. Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. Anticancer Res 26 (2006) 3939-3941
22. Coutlee F., Rouleau D., Petignat P., Ghattas G., Kornegay J.R., Schlag P., et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear Array HPV Genotyping Test. J Clin Microbiol 44 (2006) 1998-2006
23. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche Linear Array HPV Genotyping Test. J Clin Microbiol 44 (2006) 3122-3129